share_log

Morgan Stanley Maintains Equal-Weight on Organogenesis Hldgs, Raises Price Target to $3.5

Benzinga ·  Nov 14, 2023 09:31

Morgan Stanley analyst Drew Ranieri maintains Organogenesis Hldgs (NASDAQ:ORGO) with a Equal-Weight and raises the price target from $3 to $3.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment